keyword
https://read.qxmd.com/read/38652110/proteomic-studies-in-vwa1-related-neuromyopathy-allowed-new-pathophysiological-insights-and-the-definition-of-blood-biomarkers
#1
JOURNAL ARTICLE
Mohammed Athamneh, Nassam Daya, Andreas Hentschel, Andrea Gangfuss, Tobias Ruck, Adela Della Marina, Ulrike Schara-Schmidt, Albert Sickmann, Anne-Katrin Güttsches, Marcus Deschauer, Corinna Preusse, Matthias Vorgerd, Andreas Roos
Bi-allelic variants in VWA1, encoding Von Willebrand Factor A domain containing 1 protein localized to the extracellular matrix (ECM), were linked to a neuromuscular disorder with manifestation in child- or adulthood. Clinical findings indicate a neuromyopathy presenting with muscle weakness. Given that pathophysiological processes are still incompletely understood, and biomarkers are still missing, we aimed to identify blood biomarkers of pathophysiological relevance: white blood cells (WBC) and plasma derived from six VWA1-patients were investigated by proteomics...
April 2024: Journal of Cellular and Molecular Medicine
https://read.qxmd.com/read/38643439/impaired-fibrinolysis-in-patients-with-atrial-fibrillation-and-elevated-circulating-lipopolysaccharide
#2
JOURNAL ARTICLE
Marcin Sadowski, Michał Ząbczyk, Anetta Undas
It is unknown whether elevated gut-derived serum lipopolysaccharide (LPS) can affect thrombin generation, fibrinolysis, and fibrin clot properties in atrial fibrillation (AF). We aimed to evaluate associations of circulating LPS with prothrombotic markers in AF patients. A total of 157 (women, 57.3%) ambulatory anticoagulant-naïve AF patients aged from 42 to 86 years were recruited. Clinical data together with serum LPS, inflammation, endothelial injury, coagulation and fibrinolysis markers, including fibrin clot permeability (Ks ) and clot lysis time (CLT), were analyzed...
April 21, 2024: Journal of Thrombosis and Thrombolysis
https://read.qxmd.com/read/38643218/optimization-of-plasma-based-bioid-identifies-plasminogen-as-a-ligand-of-adamts13
#3
JOURNAL ARTICLE
Hasam Madarati, Veronica DeYoung, Kanwal Singh, Taylor Sparring, Andrew C Kwong, James C Fredenburgh, Cherie Teney, Marlys L Koschinsky, Michael B Boffa, Jeffrey I Weitz, Colin A Kretz
ADAMTS13, a disintegrin and metalloprotease with a thrombospondin type 1 motif, member 13, regulates the length of Von Willebrand factor (VWF) multimers and their platelet-binding activity. ADAMTS13 is constitutively secreted as an active protease and is not inhibited by circulating protease inhibitors. Therefore, the mechanisms that regulate ADAMTS13 protease activity are unknown. We performed an unbiased proteomics screen to identify ligands of ADAMTS13 by optimizing the application of BioID to plasma. Plasma BioID identified 5 plasma proteins significantly labeled by the ADAMTS13-birA* fusion, including VWF and plasminogen...
April 20, 2024: Scientific Reports
https://read.qxmd.com/read/38640438/o-glycan-determinants-regulate-vwf-trafficking-to-weibel-palade-bodies
#4
JOURNAL ARTICLE
Ellie Karampini, Dearbhla Doherty, Petra E Bürgisser, Massimiliano Garre, Ingmar Schoen, Stephanie Elliott, Ruben Bierings, James S O'Donnell
Von Willebrand factor (VWF) undergoes complex post-translational modification within endothelial cells (EC) prior to secretion. This includes significant N- and O-linked glycosylation. Previous studies have demonstrated that changes in N-linked glycan structures significantly influence VWF biosynthesis. In contrast, although abnormalities in VWF O-linked glycans (OLG) have been associated with enhanced VWF clearance, their effect on VWF biosynthesis remains poorly explored. Herein, we report a novel role for OLG determinants in regulating VWF biosynthesis and trafficking within EC...
April 19, 2024: Blood Advances
https://read.qxmd.com/read/38635764/cost-effectiveness-of-prophylaxis-with-recombinant-versus-plasma-derived-vwf-in-severe-von-willebrand-disease-in-the-us
#5
JOURNAL ARTICLE
Christina Waldron, Satoko Ito, Daniel Wang, Cecily Allen, Giri Viswanathan, Robert D Bona, Adam Cuker, George Goshua
We evaluated the cost-effectiveness of prophylaxis with rVWF versus with pdVWF for patients with severe VWD. We found that rVWF is a cost-saving factor replacement compared to pdVWF across all willingness-to-pay thresholds in the United States.
April 18, 2024: Blood
https://read.qxmd.com/read/38635535/twenty-four-week-taichi-training-improves-pulmonary-diffusion-capacity-and-glycemic-control-in-patients-with-type-2-diabetes-mellitus
#6
JOURNAL ARTICLE
Xiaoli Liu, Huan Zhu, Yong Peng, Yaofeng Liu, Xiangrong Shi
This study evaluated the effect of 24-week Taichi training and Taichi plus resistance band training on pulmonary diffusion capacity and glycemic control in patients with Type 2 diabetes mellitus (T2DM). Forty-eight patients with T2DM were randomly divided into three groups: Group A-Taichi training: practiced Taichi 60 min/day, 6 days/week for 24 weeks; Group B-Taichi plus resistance band training: practiced 60-min Taichi 4 days/week plus 60-min resistance band training 2 days/week for 24 weeks; and Group C-controls: maintaining their daily lifestyles...
2024: PloS One
https://read.qxmd.com/read/38631812/heyde-s-syndrome-a-challenging-case-of-severe-aortic-stenosis-and-gastrointestinal-bleeding
#7
JOURNAL ARTICLE
Mohamed Abouzid, Ahmed Abdelhakeem, Shorouk Elshafie, Ahmad Ghorab
We present the case of an elderly man with a history of diastolic congestive heart failure, severe aortic stenosis and atrial fibrillation, who presented with fatigue, weakness, coffee ground emesis and black tarry stool. Haemoglobin was 68 g/L. Lactate dehydrogenase was elevated at 1038. Evaluation by cardiology and gastroenterology specialists revealed reflux oesophagitis and a mild hiatal hernia on oesophagogastroduodenoscopy, normal colonoscopy and small bowel series without obstruction. Capsule endoscopy identified angiodysplasia in the small intestine...
April 17, 2024: BMJ Case Reports
https://read.qxmd.com/read/38626404/the-role-of-vascular-endothelial-dysfunction-in-hypertension-with-hearing-loss
#8
JOURNAL ARTICLE
Yinjing Hou, Bo Liu
Hypertension can cause hearing loss, but there is no clear definition of the mechanism(s) involved. The study aimed to explore the role of vascular endothelial dysfunction in hypertension with hearing loss. Patients with hypertension were divided into two groups based on hearing loss. Pure tone audiometry (PTA) and endothelial function testing were performed. A total of 216 (432 ears) hypertensive patients were divided into hypertension with hearing loss group (n = 104) and hypertension without hearing loss group (n = 112)...
April 16, 2024: Angiology
https://read.qxmd.com/read/38625829/efficacy-of-emicizumab-therapy-in-two-adult-patients-with-type-3-von-willebrand-disease
#9
JOURNAL ARTICLE
Frederick Ian LeMaistre, Elaine Chiang, Michael B Streiff, Jennifer C Yui
Type 3 von Willebrand disease (T3VWD) is a rare inherited bleeding disorder caused by the absence of von Willebrand factor (VWF). The traditional treatment for T3VWD has been VWF concentrates, but their effectiveness may be limited due to the development of alloantibodies. Emicizumab, a bispecific mAb, has shown promise in treating hemophilia A and is being studied as prophylaxis for T3VWD. In this case series, two patients with T3VWD received emicizumab prophylaxis and experienced a significant reduction in bleeding episodes and improved quality of life with fewer healthcare encounters...
March 27, 2024: Blood Coagulation & Fibrinolysis: An International Journal in Haemostasis and Thrombosis
https://read.qxmd.com/read/38621909/-mechanism-of-astragaloside-%C3%A2-combined-with-panax-notoginseng-saponins-in-regulating-angiogenesis-to-treat-cerebral-ischemia-based-on-network-pharmacology-and-experimental-verification
#10
JOURNAL ARTICLE
Yan-Ling Li, Zhan-Hui Lu, Yan-Yan Zhang, Sha-Sha Wu, Tian-Hao Xie, Huang Ding, Wei Zhang, Xiao-Dan Liu, Chang-Qing Deng
Network pharmacology and animal and cell experiments were employed to explore the mechanism of astragaloside Ⅳ(AST Ⅳ) combined with Panax notoginseng saponins(PNS) in regulating angiogenesis to treat cerebral ischemia. The method of network pharmacology was used to predict the possible mechanisms of AST Ⅳ and PNS in treating cerebral ischemia by mediating angiogenesis. In vivo experiment: SD rats were randomized into sham, model, and AST Ⅳ(10 mg·kg~(-1)) + PNS(25 mg·kg~(-1)) groups, and the model of cerebral ischemia was established with middle cerebral artery occlusion(MCAO) method...
February 2024: Zhongguo Zhong Yao za Zhi, Zhongguo Zhongyao Zazhi, China Journal of Chinese Materia Medica
https://read.qxmd.com/read/38619683/inhibiting-mmp13-attenuates-deep-vein-thrombosis-in-a-mouse-model-by-reducing-the-expression-of-pdpn
#11
JOURNAL ARTICLE
Ji Luo, Jin Zhou, Jing-Zeng Luo, Hai-Long Wang, Xue-Ling Zhao, Ru-Dan Zhou
OBJECTIVE: Matrix metalloproteinase 13 (MMP13) is an extracellular matrix protease that affects the progression of atherosclerotic plaques and arterial thrombi by degrading collagens, modifying protein structures and regulating inflammatory responses, but its role in deep vein thrombosis (DVT) has not been determined. The purpose of this study was to investigate the potential effects of MMP13 and MMP13-related genes on the formation of DVT. METHODS: We altered the expression level of MMP13 in vivo and conducted a transcriptome study to examine the expression and relationship between MMP13 and MMP13-related genes in a mouse model of DVT...
April 15, 2024: Current Medical Science
https://read.qxmd.com/read/38618505/factor-viii-as-a-novel-biomarker-for-diagnosis-prognosis-and-therapy-prediction-in-human-cancer-and-other-disorders
#12
REVIEW
Sheyda Khalilian, Zahra Mohajer, Soudeh Ghafouri-Fard
Coagulation factor VIII (FVIII) is an essential cofactor in the coagulation cascade, encoded by the F8 gene on the long arm of chromosome X (Xq28). FVIII is normally circulated in complex with Von Willebrand factor (VWF) and has relevant emerging extracoagulative functions. Dysregulation of FVIII is associated with tumor progression, and could be used as a novel biomarker for tumor screening and monitoring. In breast cancer, bladder cancer, colorectal carcinoma, esophageal carcinoma, hepatocellular carcinoma and lung cancer, F8 is regarded as an oncogene...
2024: Avicenna Journal of Medical Biotechnology
https://read.qxmd.com/read/38616335/selecting-potential-biomarkers-of-plasma-proteins-in-mares-with-endometritis
#13
JOURNAL ARTICLE
Xijun Zhang, Zhanhai Mai, Yujin Gao, Xingxu Zhao, Yong Zhang
BACKGROUND: Endometritis is a common condition in mares that causes significant economic loss. Lacking obvious clinical signs, the clinical diagnosis of endometritis in mares relies on case-by-case clinical examinations, which can be particularly inefficient in large-scale farms. Therefore, the identification of potential biomarkers can serve as a non-invasive and efficient screening technique for endometritis in mares. OBJECTIVES: To compare the blood proteome between fertile mares and mares with endometritis to identify biomarkers potentially associated with the development of endometritis and validate their predictive potential...
April 14, 2024: Equine Veterinary Journal
https://read.qxmd.com/read/38614263/network-pharmacology-analysis-and-experimental-verification-of-the-antithrombotic-active-compounds-of-trichosanthis-pericarpium-gualoupi-in-treating-coronary-heart-disease
#14
JOURNAL ARTICLE
Kai-Rou Xia, Xiao-Yu Zhang, Huang-Qin Zhang, Ke-Lei Su, Er-Xin Shang, Qing-Ling Xiao, Wei-Wen Li, Sheng Guo, Jin-Ao Duan, Pei Liu
ETHNOPHARMACOLOGICAL RELEVANCE: Trichosanthis pericarpium (TP; Gualoupi, pericarps of Trichosanthes kirilowii Maxim) has been used in traditional Chinese medicine (TCM) to reduce heat, resolve phlegm, promote Qi, and clear chest congestion. It is also an essential herbal ingredient in the "Gualou Xiebai" formula first recorded by Zhang Zhongjing (from the Eastern Han Dynasty) in the famous TCM classic "Jin-Guì-Yào-Lüe" for treating chest impediments. According to its traditional description, Gualou Xiebai is indicated for symptoms of chest impediments, which correspond to coronary heart diseases (CHD)...
April 13, 2024: Journal of Ethnopharmacology
https://read.qxmd.com/read/38608731/the-proteasome-inhibitor-carfilzomib-exerts-anti-inflammatory-and-anti-thrombotic-effects-on-the-endothelium
#15
JOURNAL ARTICLE
Ahmed Hjazi, Celia Gonzalez Maroto, Michael Appiah, Maria Elena Rodriguez-Gutierrez, Ana Ignat, Golzar Mobayen, Theresa Page, Thomas A J McKinnon
BACKGROUND: Carfilzomib (CFZ) is a second-generation proteasome inhibitor used to treat multiple myeloma. Potent inhibition of the proteasome results in chronic proteotoxic endoplasmic reticulum (ER) stress, leading to apoptosis. While CFZ has improved survival rates in multiple myeloma, it is associated with an increased risk of cardiovascular adverse effects. While this has been putatively linked to cardiotoxicity, CFZ could potentially also exhibit adverse effects on the endothelium...
April 10, 2024: Journal of Thrombosis and Haemostasis: JTH
https://read.qxmd.com/read/38608066/evaluating-the-potential-mediating-role-of-adamts13-activity-in-the-relationship-between-obesity-and-the-severity-of-covid-19-a-retrospective-cohort-study
#16
JOURNAL ARTICLE
Wael Hafez, Asrar Rashid, Hesham Mohamed Abuelsaoud, Mohan Jose, Samy Kishk, Muneir Gador, Tesfalidet Emoshe, Fatema Abdulaal, Nivedita Nair, Muhammad Ahmad, Vanya Jalal Rashid, Youmna Faheem, Steffi John, Sabah Ahmed, Ahmed Daraghmi, Rami Soliman, Ahmed Abdelrahman, Ahmed Ali Mohamed, Mirvat Ghanem
Obesity and low enzyme A disintegrin and metalloproteinase with thrombospondin type-1 motif-13 (ADAMTS13) activity have been linked to poor coronavirus disease 2019 (COVID-19). Given that obesity may influence ADAMTS13 activity, it is feasible; however, it remains unclear whether ADAMTS13 activity acts as a mediator between obesity and COVID-19 outcomes. We investigated the link between body mass index (BMI) and COVID-19 outcomes, using ADAMTS13 activity as a mediator. ADAMTS13 activity was measured in 86 hospitalized COVID-19 patients...
April 12, 2024: Medicine (Baltimore)
https://read.qxmd.com/read/38607272/awareness-of-von-willebrand-disease-among-gynecologists-investigating-the-referral-of-women-with-heavy-menstrual-bleeding-to-hematologists
#17
JOURNAL ARTICLE
Jolana Schmiedl, Giancarlo Castaman
No abstract text is available yet for this article.
April 12, 2024: International Journal of Gynaecology and Obstetrics
https://read.qxmd.com/read/38606222/a-review-about-the-assessment-of-the-bleeding-and-thrombosis-risk-for-patients-with-myeloproliferative-neoplasms-scheduled-for-surgery
#18
REVIEW
Mihaela Andreescu, Bogdan Andreescu
Myeloproliferative neoplasms (MPNs) present a unique challenge in surgical management due to their inherent predisposition to both bleeding and thrombosis. MPNs are a heterogenous group of acquired clonal conditions. The three classic MPNs are essential thrombocythemia (ET), myelofibrosis (PMF), and polycythemia vera (PV). All subtypes of MPN are associated with both thrombotic and bleeding complications. There are four risk categories for thrombosis in MPN patients: age, thrombosis history, and JAK -2 mutation...
March 2024: Curēus
https://read.qxmd.com/read/38598839/mortality-cardiac-and-cerebral-damages-reduction-by-il-1-inhibition-in-a-murine-model-of-ttp
#19
JOURNAL ARTICLE
Romain Muller, Raphael Cauchois, Marie Lagarde, Sandrine Roffino, Cecile Genovesio, Samantha Fernandez, Guillaume Hache, Benjamin Guillet, Yeter Kara, Marion Marlinge, Peter J Lenting, Pascale Poullin, Françoise Dignat-George, Edwige Tellier, Gilles Kaplanski
Thrombotic thrombocytopenic purpura (TTP), a rare but fatal disease if untreated, is due to alteration in Von Willebrand factor cleavage resulting in capillary microthrombi formation and ischemic organ damage. Interleukin-1 (IL-1), has been shown to drive sterile inflammation following ischemia and could play an essential contribution to post-ischemic organ damage in TTP. Our objectives were to evaluate IL-1 involvement during TTP and to test the efficacy of the recombinant IL-1 receptor antagonist, anakinra, in a murine TTP model...
April 5, 2024: Blood
https://read.qxmd.com/read/38595335/factor-viii-and-von-willebrand-factor-are-wavering-proteins-the-basis-for-the-therapeutic-development-of-desmopressin
#20
JOURNAL ARTICLE
Pier Mannuccio Mannucci, Simona Maria Siboni
No abstract text is available yet for this article.
February 2024: Research and Practice in Thrombosis and Haemostasis
keyword
keyword
81953
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.